- Home
- APXT vs BBNX Comparison
APXT vs BBNX Comparison
Compare APXT & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APXT | BBNX |
|---|---|---|
| Founded | 2025 | 2015 |
| Country | United States | United States |
| Employees | 4 | 423 |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 457.3M | 493.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | APXT | BBNX |
|---|---|---|
| Price | $10.00 | $12.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $24.00 |
| AVG Volume (30 Days) | 28.9K | ★ 1.1M |
| Earning Date | 01-01-0001 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $34.90 |
| Revenue Next Year | N/A | $34.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.87 | $8.80 |
| 52 Week High | $10.00 | $32.71 |
Technical Indicators
Market Signals| Indicator | APXT | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 56.97 | 60.58 |
| Support Level | N/A | $12.48 |
| Resistance Level | $10.00 | $15.53 |
| Average True Range (ATR) | 0.01 | 0.92 |
| MACD | 0.00 | 0.48 |
| Stochastic Oscillator | 92.86 | 88.46 |
Price Performance
Historical ComparisonAbout APXT Apex Treasury Corporation Class A Ordinary Share
Apex Treasury Corp is a blank check company established for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.